Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma.

Khier, Sonia

Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma. [electronic resource] - European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Jan 2010 - 23-9 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1879-0720

10.1016/j.ejps.2009.10.006 doi


Aminoquinolines--pharmacology
Animals
Antineoplastic Agents--pharmacokinetics
Cell Line, Tumor
Dose-Response Relationship, Drug
Humans
Imidazoles--pharmacokinetics
Imiquimod
Injections, Intraperitoneal
Injections, Intravenous
Male
Melanoma--drug therapy
Mice
Mice, Nude
Nitrosourea Compounds--pharmacology
Organophosphorus Compounds--pharmacology
Quinoxalines--administration & dosage
Rats
Skin Neoplasms--drug therapy
Xenograft Model Antitumor Assays